title: Effective treatment with recombinant factor VIIa of severe bleeding due to acquired factor VIII inhibitor and acquired thrombocytopathy.
authors.forename: Venancio
authors.initials: V
authors.lastname: Conesa
authors.forename: Angela
authors.initials: A
authors.lastname: Mompel
authors.forename: Francisco
authors.initials: F
authors.lastname: Lopez
authors.forename: Francisca
authors.initials: F
authors.lastname: Marín
authors.forename: Jose
authors.initials: J
authors.lastname: Ruiz
authors.forename: Francisco
authors.initials: F
authors.lastname: Navarro
authors.forename: Amparo
authors.initials: A
authors.lastname: Gomez
mesh_terms: D000368:Aged; D005167:Factor VII / Q000008:administration & dosage*; D015942:Factor VIIa; D017809:Fatal Outcome; D006395:Hemarthrosis / Q000188:drug therapy / Q000209:etiology; D019337:Hematologic Neoplasms / Q000150:complications; D006406:Hematoma / Q000188:drug therapy / Q000209:etiology; D006467:Hemophilia A / Q000188:drug therapy / Q000209:etiology*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa